IGF1R and breast carcinoma: In breast cancer, metabolism is, in part, responsible for metastatic spread via dysregulation of the IGF-1R/Akt pathway, which directly influences tumor progression and plays a role in the fate of anchoring metastases to the tumor microenvironment [22,23,24].